Chris Cohen

Chris Cohen currently serves as Vice President and Head of Clinical Safety and Pharmacovigilance at Pyxis Oncology, a position held since May 2025. Previously, Chris was Associate Vice President of Clinical Safety and Risk Management at Merck, where responsibilities included directing safety and risk management for oncology products. Prior to Merck, Chris held the position of Executive Director and Head of Pharmacovigilance at Immunocore, overseeing a team and managing agreements with Contract Research Organizations. Chris's extensive experience also includes senior roles at GSK, where safety activities for a diverse portfolio of investigational products were led, as well as positions at Wyeth Research focusing on safety support for vaccines and anti-infectives. Chris holds a Bachelor's Degree in Biology from Swarthmore College and an M.D. from Yale School of Medicine.